Navnita Dutta

2PUBLICATIONS
33CO-AUTHORS
Molecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 21, 2023
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.

Sikander Ailawadhi, Ricardo D Parrondo, Navnita Dutta

|Sep 01, 2022
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy.

Jing Deng, Aneel Paulus, Douglas D Fang

Pageof 1